Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

The Israeli study was conducted among 109,000 patients who were 40 years old or older.

READ MORE
 

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

‘Vaccinated Will Definitely Have More Freedoms Than Unvaccinated’

(AP) -- BERLIN – German politicians were deeply divided…
Read more

Britain: Boris Johnson to Introduce Junk Food Credit Score App

Prime Minister Boris Johnson is set to launch a communist China-style…
Read more

Alarm in Jerusalem as Iran Races to The Bomb Amid Lull in Nuclear Talks

Iran is taking advantage of the lull in nuclear talks with…
Read more